ÔÆÌ⺣ - רҵÎÄÕ·¶ÀýÎĵµ×ÊÁÏ·ÖÏíÆ½Ì¨

µ±Ç°Î»ÖãºÊ×Ò³ > cas9Ñо¿ÀúÊ·£¨×ª×ÔÒ»¸öÑо¿Éú×÷Òµ£©£¨ÕâÊǽñÄê5Ô·Ýд¸øÎâηÀÏʦµÄ£© - ͼÎÄ

cas9Ñо¿ÀúÊ·£¨×ª×ÔÒ»¸öÑо¿Éú×÷Òµ£©£¨ÕâÊǽñÄê5Ô·Ýд¸øÎâηÀÏʦµÄ£© - ͼÎÄ

  • 62 ´ÎÔĶÁ
  • 3 ´ÎÏÂÔØ
  • 2025/5/1 19:27:08

È˿޵ϰ£¬ÄǾÍÒ»¶¨ÊÇTALENÏà¹Ø¹«Ë¾ÁË¡£

ÕýËùν¡°³¤½­ºóÀËÍÆÇ°ÀË£¬Ç°ÀËËÀÔÚɳ̲ÉÏ¡±£¬¿ÆÑ§Ò²Óиüл»´ú£¬ËãÊÇ×ÔÈ»¹æÂÉʹȻ¡£Cas9ÎÞÂÛÊÇ´ÓÀíÂÛ·ÖÎö£¬¿ÉÐÐÐÔ±ã½ÝÐÔ£¬»¹ÊÇʵ¼Ê½á¹û£¬Ð§ÂÊÉ϶¼ÇáËɵġ°Ãëɱ¡±ÁËǰÈÎÃ÷ÐÇ¡ª¡ªTALEN¡£¡¾1¡¿¡¾17¡¿¡¾19¡¿¡¾21¡¿. û°ì·¨£¬ÔÚ±ü³ÐÁË¡°¸ü¸ß¡¢¸ü¿ì¡¢¸üÇ¿¡±¾«ÉñµÄCas9Í¬Ñ§ÃæÇ°£¬Ôø¾­·ç¹âÎÞÏÞµÄTALENͬѧֻÄÜĬĬ´¹ÀáÀëÈ¥£¬Ê£ÏÂÒ»¶Ñ¹«Ë¾×öºÃ×¼±¸Ñª±¾ÎÞ¹éÁË¡£

°Ù»¨Æë·Å£¬Ëĺ£½Ô×¼

HumanÕâ¸ö´óboss¶¼¸ãµàÁË£¬Ê£ÏµĹÀ¼ÆÎÊÌâ²»´ó¡£Ò²µÄÈ·ÊÇÕâÑù£¬Ò»Ê±¼ä£¬¸÷ÖÖÎïÖÖÌåÄÚµÄCas9ÔËÓÃÎÄÕ»©À²À²µÄð³öÀ´¡ª¡ª°ßÂíÓ㡾24¡¿½Íĸ¡¾25¡¿Ð¡Ê󣨶à»ùÒòͬʱ£¬»¹ÊÇ´ÔÀÖÀϰå¿ÎÌâ×éµÄ×÷Æ·£©¡¾26¡¿Ï¸¾ú£¨ÈÔÈ»ÊÇ´ÔÀÖÀϰå¿ÎÌâ×é×÷Æ·£©¡¾27¡¿£¬Cas9´óÈÈÕýʽ³öÏÖ¡£

ÑÛ¿´£¬Ò»¸öCas9µÄʱ´ú¾ÍÕâÑùµ½À´ÁË¡£

¾«È·¶¨Î»£¬Ç±Á¦ÎÞÇî

Æäʵ£¬Cas9µÄ³É¹¦¸øÁËÎÒÃÇÒ»¸öÔËÓÃCRISPRϵͳ·½±ã¿ì½Ý¶¨Î»»ùÒòÐòÁеĿÉÄÜ£¬µ«½ö½ö¾ÖÏÞÓڱ༭»ùÒòÂð£¿Æäʵ¿ÉÒÔ×öµÄÔ¶²»Ö¹ÓÚ´Ë¡£

ͼ17 ÀûÓÃCas9¶¨Î»¿ØÖÆ×ªÂ¼¡¾28¡¿

±ÈÈç¿ÉÒÔÀûÓÃÕâÖÖÌØÒìÐÔ£¬×öÓÐÕë¶ÔÐԵıí´ïµ÷¿Ø¡¾28¡¿£¬±ÈÈçÀûÓÃË«ÇÐÖÂËÀÐÔ¡°×Ô¶¯¡±É¸Ñ¡Í»±äÖ꡾27¡¿¡£Î´À´£¬Ò²Ðí»¹Óиü¶àÓ¦Ó㬿ª¶¯ÄÔ½î¸ÄÔìËû£¬»¹ÓкܴóDZÁ¦¡£

ËÄ¡¢¾ªÏ²Á¬Á¬£¬ÆæÃî¼ÌÐø

¡ª¡ªCRISPRϵͳÔÚ¸÷¸ö²ã´ÎµÄ¹ã·ºÐÔÓë¸øÎÒÃǵÄÈÏÖªÍØÕ¹

Ö÷¹ÛÀ´½²£¬Ò»¸öºÃ¹ÊʵĽáβ×ÜÊÇÁôÓÐÐüÄîµÄ¿ª·Åʽ£¬ÎªÁ˽²¸öºÃ¹ÊÊ£¬ÎÒÃǵÄCRISPRÒ²²»¸ºÖØÍû£¬¸ü¶à·¢ÏÖ£¬ÈÃÎÒÔÙ¶àдһ½Ú¡£

¿Í¹ÛÀ´½²£¬Äܹ»¿ªÆôÒ»¸ö·Ö×ÓÉúÎïѧµÄоÖÃæÒѾ­¹»Å£ÆøÁË£¬¿ÉÊÇÆ«Æ«È˼һ¹Óиü´óµÄʹÃü¡ª¡ªÈÃÎÒÃǼÌÐøË¼¿¼Ô­ºËµÄÖÖÖÖ£¬µ÷¿ØÍøÂçµÄÖÖÖÖ¡£

µÀ¸ßÒ»³ßħ¸ßÒ»ÕÉ¡ª¡ª²¡¶¾¿¹CRISPRϵͳ»úÖÆ

ÓиöÎÊÌâ²»ÖªµÀ´ó¼ÒÓÐûÓÐÏë¹ý£¬Èç¹ûCRISPRÔÚÔ­ºËÉúÎïÖÐÕæµÄÄÇôËùÏòÅûÃÒ£¬ÄÇÊɾúÌå¡¢²¡¶¾¶ÔÓÚϸ¾úÔç¾ÍûÈκÎÍþвÄÜÁ¦ÁË£¬Ôç¾Í¸ø¸ÉµôÁË¡£¡°Õâ²»¿ÆÑ§°¡¡±~ Ë×»°Ëµ¡°µÀ¸ßÒ»³ßħ¸ßÒ»ÕÉ¡±£¬Äãϸ¾úÄÜÓÐCRISPR¶Ô¸¶ÎÒ²¡¶¾£¬ÎÒ²¡¶¾Ò²±ØÈ»ÓÐÒ»Ì×ÉõÖÁ¼¸Ì×»úÀíÀ´¶Ô¸¶Äã¡£¡¾6¡¿¡¾31¡¿ ¡°±ðÄö¹°ü²»µ±¸ÉÁ¸¡±£¬±ðÄò¡¶¾²»µ±ÉúÃü£¬È˼Ҳ»µ«ÄÜ¡°½èʬ»¹»ê¡±·±Ö³×Ô¼º£¬Á¬ÌØÒìÐÔµÄÃâÒßϵͳ£¬¶¼ÊÇ¿ÉÒÔÓеģ¡

°ÂÌØÂüÓëС¹ÖÊÞ¹²Í¬³É³¤¡ª¡ª¡ª¾ü±¸¾ºÈü£¬Ð­Í¬½ø»¯

ÕýÈçÕâ¸öÓÐȤµÄÌâÄ¿CRISPR-mediated phage resistance and the ghost of coevolution past¡¾33¡¿£¬ÈÃÎÒÃǸÐÐËȤµÄÊÇCRISPRϵͳÖÐÄÇЩϸ¾ú²¡¶¾Ð­Í¬½ø»¯µÄÖ¤¾Ý¡£¡¾31¡¿ÖÐÊɾúÌå¶Ô¿¹CRISPR»ùÒòÀ´Ô´µÈ±íÃ÷£¬Ï¸¾úºÍÊɾúÌå¼òÖ±¡°ÄãÖÐÓÐÎÒ¡±¡°ÎÒÖÐÓÐÄ㡱£¬²»¶Ï¾ºÕù£¬¹²Í¬³É³¤¡£

ÏëÒ»Ï룬´ó×ÔÈ»µÄ·¨Ôò¶àôÓÐÕÜѧÒâÒå°¡£¡

¿àÈâ¼Æ¡ª¡ª×ÔÉí¿¹Äæ£¬×÷ÓñÈÎÒÃÇÏëµÄ¸ü¶à

¸üÐþÃîµÄ»úÖÆÊÇÕâ¸ö¡°¿àÈâ¼Æ¡±¡ª¡ªÏ¸¾úͨ¹ýCRISPRµ÷½Ú×ÔÉí»ùÒò£¬°ïÖú×Ô¼º¶ã±Ü²¸È鶯ÎïµÄÃâÒßϵͳ¡£

2013Äê4ÔµÄһƪÎÄÕ¡¾5¡¿±íÃ÷ϸ¾úFrancisella novicidaµÄ´«È¾Á¦ÒÀÀµ×ÔÉíµÄCRISPRϵͳ¡£ ÔÚ²¸È鶯Îïϸ°ûÄÚÉú³¤Ê±£¬Ï¸¾ú»áͨ¹ýCRISPRϵͳ¹Ø±Õ×ÔÉíÖ¬µ°°×µÄºÏ³É»ùÒò£¬ÒÔ±ÜÃâ±»ËÞÖ÷ÃâÒßϵͳ·¢ÏÖ²¢´Ý»Ù¡£

¡°Èç¹û½«ËÞÖ÷µÄÃâÒßϸ°û±È×÷´óº£ÖеÄöèÓ㣬ÄÇô¶ÔÓÚËüÃÇÀ´Ëµ£¬Ï¸¾úÖ¬µ°°×¾ÍÈçͬº£Ë®ÀïµÄѪһ°ã³äÂú×ÅÎüÒýÁ¦¡£Òò´Ë£¬ÎªÁ˲»±»ÃâÒßϵͳ·¢ÏÖ£¬Ï¸¾ú¾Í±ØÐë¹Ø±ÕÖ¬µ°°×µÄÉú²ú¡£¡± Ì«ÉñÆæÁË£¡

¡°³ýÁËÇиîÊɾúÌå»ùÒòÒÔÍ⣬Cas9»¹Äܹ»µ÷½Úϸ¾ú»ùÒò£¬ÕâÊÇÒ»Ïîз¢ÏÖ£¬¡±

¿´À´CRISPRϵͳÊÇÒ»ÖÖÔ­ºËÉúÎï¼ä¡¢Ô­ºËºÍÕæºËÖ®¼ä×ÛºÏÐԵĵ÷¿ØÍøÂçµÄÖÐÐÄ£¬ÊÇÔ­ºËÉúÎïµÖÓùÍâ½ç²»Á¼»·¾³µÄÊֶη½·¨£¬²¢·ÇÇÐÇÐÍâÔ´»ùÒòÄÇô¼òµ¥¡£Ò²¸øÁËÎÒÃÇÒ»¸ö»ú»á£¬

ÈÃÎÒÃÇ´ÓCRISPRµÄ½Ç¶ÈÖØÐÂÈÏʶһÏÂÆæÃîµÄ¡°Î¢ÉúÎï½ç¡±¡£

µ±È»£¬»¹Óиü¶à¹ØÓÚCRISPRµÄ±¨µÀ¡¾32¡¿Òýµ¼ÎÒÃǼÌÐøÈ¥¹Ø×¢¡£

¡°Ð¡¶«Î÷¡±¸ã³ö¡°´óÃûÌá±¹Êʵġ°Æôʾ¡±

ºÃÀ²£¬¹Êʽ²µ½ÕâÀïÒ²²î²»¶àÁË£¬ÊÇʱºò×ܽáÒ»ÏÂÀ²£¬¹Êʹ£¸ÅÈçͼËùʾ£¬¶à˵һ±éҲûɶÒâ˼¡£

¡°²»Ðҵĸ÷Óи÷µÄ²»ÐÒ£¬ÐÒÔ˵ͼ²î²»¶àÒ»¸öÑù×Ó¡£¡±ÆäʵÏëÏ룬ҲÐíÕâ¾ÍÊÇÒ»¸öniceµÄ¿ÆÑ§¹ÊʸÃÓеÄpattern¡ª¡ª´Ó×î³õһƬ²ÝçÖб»»ÛÑÛʶӢÐÛ£¬µ½Ñо¿²»¶ÏÉ£¬´ò¿ªÒ»Æ¬ÈÏÖªÐÂÌìµØ£¬ÉõÖÁ¸Äд¹ÌÓС°½Ì¿ÆÊ顱£¬¸Ä±ä¹ÌÓйÛÄî¡£¶øºóÅÉÉÏÓ󡣬Ϊ¸ü¶àÑо¿·þÎñ¡£²¢ÇÒͬʱ¿ªÆôÒ»¸öÐÂÁìÓò£¬ÐÂÊÓÒ°¡£

È»¶øÕâ¸ö¹ÊʵÄÒâÒ廹ÔÚÓÚÌáÐÑÎÒÃÇÔõô×öºÃµÄÑо¿£¬»Ø¹ËÕû¸ö¹ÊÊ£¬ÆäʵÎÞÂÛÔÚÄÄÀPʱ½øÈëÓÐËù½¨Ê÷¶¼ÊǺܺõÄÑо¿¡£¹Ø¼üÔÚÓÚÈçºÎÃôÈñµÄ·¢ÏÖÕâ×ÔÈ»±¦²ØµÄ¼ÛÖµËùÔÚ£¬¿´µÃ±È±ðÈËÔ¶£¬ÏÂÊֱȱðÈËÔ磬¶øÇÒ¶¯×÷±È±ðÈ˿졣

×ÔÈ»½çÓкܶ౦²Ø£¬¹Ö²»µÃventerҪϺ£È¥ÕÒ¡£ÎÒÃÇ¿ÉÒÔ²»È¥ÕÒ£¬¾Í¶¢×ÅÄÇЩ³öÍÁµÄ£¬Ðá¾õÁéÃô£¬»ÛÑÛʶÖ飬ÓÐÁËmake a differenceµÄ»úÓö£¬¹û¶Ïץס£¡

Ï£ÍûÔÙÓÐÕâÑùµÄºÃ¡°Ï·¡±£¬ÎÒÃDz»µ«ÔŲ́ÉÏ£¬³ªµÄ»¹ÊǸ߳±²¿·Ö~

Reference

[1] Le Cong, F. Ann Ran, David Cox, et al. Multiplex Genome Engineering Using CRISPR/Cas Systems, Science,2013, Vol. 339 no. 6121 pp. 819-823 DOI: 10.1126/science.1231143

[2] M. Jinek et al ., A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science337, 816(2012).doi:10.1126/science.1225829 Medline [3] Philippe Horvath, Rodolphe Barrangou, CRISPR/Cas, the Immune System of Bacteria and Archaea , Science ,DOI: 10.1126/science.1179555, 167 (2010); 327

[4] Rimantas Sapranauskas, et al ., The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli , Nucleic Acids Research, 2011, Vol. 39, No. 21 9275¨C9282

[5] Timothy R. Sampson et al ., A CRISPR/Cas system mediates bacterial innate immune evasion and virulence, Nature, doi:10.1038/nature12048

[6] Kimberley D. Seed et al ., A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity, Nature, doi:10.1038/nature11927

[7] YOSHI ZUMI ISHINO, et al.,Nucleotide Sequence of the iap Gene, Responsible for Alkaline Phosphatase Isozyme Conversion in Escherichia coli, and IdentificationoftheGeneProduct, JOURNAL OF BACTERIOLOGY, Dec. 1987, p. 5429-5433 [8] Ruud. Jansen, et al ., Identification of genes that are associated with DNA repeats in prokaryotes, Molecular Microbiology (2002) 43(6), 1565¨C1575

[9] Matthijs M Jore ,et al ., Structural basis for CRISPR RNA-guided DNA recognition by Cascade, Nature Structural & Molecular Biology,2011 doi:10.1038/nsmb.2019

[10] Caryn R. Hale et al ., Essential Features and Rational Design of CRISPR RNAs that Function with the Cas RAMP Module Complex to Cleave RNAs, Molecular Cell,45, 292¨C302, February 10, 2012

[11] Blake Wiedenheft , et al ., RNA-guided genetic silencing systems in bacteria and archaea, Nature, 2012, doi:10.1038/nature10886

[12] Ibtissem Grissa et al ., CRISPRFinder: a web tool to identify clustered regularly interspaced short palindromic repeats Nucleic Acids Research, 2007, Vol. 35, Web Server issuedoi:10.1093/nar/gkm360

[13] Giedrius Gasiunas, et al ., Cas9 ¨CcrRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria, PNAS, September 4, 2012 | E2579 ¨CE2586

[14] Zihni Arslan et al ., Double-strand DNA end-binding and sliding of the toroidal

  • ÊÕ²Ø
  • Î¥¹æ¾Ù±¨
  • °æÈ¨ÈÏÁì
ÏÂÔØÎĵµ10.00 Ôª ¼ÓÈëVIPÃâ·ÑÏÂÔØ
ÍÆ¼öÏÂÔØ
±¾ÎÄ×÷Õߣº...

¹²·ÖÏí92ƪÏà¹ØÎĵµ

Îĵµ¼ò½é£º

È˿޵ϰ£¬ÄǾÍÒ»¶¨ÊÇTALENÏà¹Ø¹«Ë¾ÁË¡£ ÕýËùν¡°³¤½­ºóÀËÍÆÇ°ÀË£¬Ç°ÀËËÀÔÚɳ̲ÉÏ¡±£¬¿ÆÑ§Ò²Óиüл»´ú£¬ËãÊÇ×ÔÈ»¹æÂÉʹȻ¡£Cas9ÎÞÂÛÊÇ´ÓÀíÂÛ·ÖÎö£¬¿ÉÐÐÐÔ±ã½ÝÐÔ£¬»¹ÊÇʵ¼Ê½á¹û£¬Ð§ÂÊÉ϶¼ÇáËɵġ°Ãëɱ¡±ÁËǰÈÎÃ÷ÐÇ¡ª¡ªTALEN¡£¡¾1¡¿¡¾17¡¿¡¾19¡¿¡¾21¡¿. û°ì·¨£¬ÔÚ±ü³ÐÁË¡°¸ü¸ß¡¢¸ü¿ì¡¢¸üÇ¿¡±¾«ÉñµÄCas9Í¬Ñ§ÃæÇ°£¬Ôø¾­·ç¹âÎÞÏÞµÄTALENͬѧֻÄÜĬĬ´¹ÀáÀëÈ¥£¬Ê£ÏÂÒ»¶Ñ¹«Ë¾×öºÃ×¼±¸Ñª±¾ÎÞ¹éÁË¡£ °Ù»¨Æë·Å£¬Ëĺ£½Ô×¼ HumanÕâ¸ö´óboss¶¼¸ãµàÁË£¬Ê£ÏµĹÀ¼ÆÎÊÌâ²»´ó¡£Ò²µÄÈ·ÊÇÕâÑù£¬Ò»Ê±¼ä£¬¸÷ÖÖÎïÖÖÌåÄÚµÄCas9ÔËÓÃÎÄÕ»©À²À²µÄð³öÀ´¡ª¡ª°ßÂíÓ㡾24¡¿½Íĸ¡¾25¡¿Ð¡Ê󣨶à»ùÒòͬʱ£¬»¹ÊÇ´ÔÀÖÀϰå¿ÎÌâ×éµÄ×÷Æ·£©¡¾26¡¿Ï¸¾ú£¨ÈÔÈ»ÊÇ´ÔÀÖÀϰå¿ÎÌâ×é×÷Æ·£©¡¾27¡¿£¬Cas9´óÈÈÕýʽ³öÏÖ¡£

¡Á ÓοͿì½ÝÏÂÔØÍ¨µÀ£¨ÏÂÔØºó¿ÉÒÔ×ÔÓɸ´ÖƺÍÅŰ棩
µ¥Æª¸¶·ÑÏÂÔØ
ÏÞÊ±ÌØ¼Û£º10 Ôª/·Ý Ô­¼Û:20Ôª
VIP°üÔÂÏÂÔØ
ÌØ¼Û£º29 Ôª/Ô ԭ¼Û:99Ôª
µÍÖÁ 0.3 Ôª/·Ý ÿÔÂÏÂÔØ150·Ý
ȫվÄÚÈÝÃâ·Ñ×ÔÓɸ´ÖÆ
VIP°üÔÂÏÂÔØ
ÌØ¼Û£º29 Ôª/Ô ԭ¼Û:99Ôª
µÍÖÁ 0.3 Ôª/·Ý ÿÔÂÏÂÔØ150·Ý
ȫվÄÚÈÝÃâ·Ñ×ÔÓɸ´ÖÆ
×¢£ºÏÂÔØÎĵµÓпÉÄÜ¡°Ö»ÓÐĿ¼»òÕßÄÚÈݲ»È«¡±µÈÇé¿ö£¬ÇëÏÂÔØÖ®Ç°×¢Òâ±æ±ð£¬Èç¹ûÄúÒѸ¶·ÑÇÒÎÞ·¨ÏÂÔØ»òÄÚÈÝÓÐÎÊÌ⣬ÇëÁªÏµÎÒÃÇЭÖúÄã´¦Àí¡£
΢ÐÅ£ºfanwen365 QQ£º370150219
Copyright © ÔÆÌ⺣ All Rights Reserved. ËÕICP±¸16052595ºÅ-3 ÍøÕ¾µØÍ¼ ¿Í·þQQ£º370150219 ÓÊÏ䣺370150219@qq.com